China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom
China's drug regulator has approved a significant number of innovative medicines developed domestically, reflecting a growing biotech sector. This move is part of China's broader strategy to enhance its pharmaceutical industry and reduce reliance on foreign drugs. The approvals are expected to boost the availability of new treatments for various diseases in the Chinese market.
- ▪China's drug regulator has cleared a wave of home-grown innovative medicines.
- ▪The approvals are part of a strategy to strengthen the domestic pharmaceutical industry.
- ▪This initiative aims to reduce dependence on foreign medications.
Opening excerpt (first ~120 words) tap to expand
.css-1e339y7{z-index:1400;}.css-1e339y7 .MuiDrawer-paper{overflow-y:hidden;}.css-1e339y7 .MuiDrawer-modal{background:rgba(0, 0, 0, 0.2);}.css-1h2k762{z-index:1200;z-index:1400;}.css-1h2k762 .MuiDrawer-paper{overflow-y:hidden;}.css-1h2k762 .MuiDrawer-modal{background:rgba(0, 0, 0, 0.2);}.css-1whztno{position:relative;}.css-1whztno:first-of-type .er6t7fe40>*:first-child{padding-block-start:0;}.css-ahnbry>*:first-child{padding-block:var(--mobile-widget-gap, 16px);}@media (min-width:768px){.css-ahnbry>*:first-child{padding-block:40px;}}.css-hhdj32{--content-tablet-up-max-inline-size:600px;--widget-extra-padding:12px;--mobile-widget-gap:16px;--desktop-widget-gap:18px;display:grid;grid:"header-container" min-content "leading" min-content "content-container" min-content "widgets-bottom"…
Excerpt limited to ~120 words for fair-use compliance. The full article is at South China Morning Post.